ArticleWorld journal of microbiology & biotechnology2026
Inhibitory effects of esculetin as a quorum sensing inhibitor on biofilm formation and virulence factors in Vibrio anguillarum.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Vibrio anguillarum (V. anguillarum) causes vibriosis in aquaculture, with pathogenicity regulated by quorum sensing (QS). Inhibiting QS is a promising anti-virulence strategy. Plant-derived compounds are attractive due to their safety and low resistance potential. Here, we screened 33 natural compounds and found that esculetin, a coumarin, inhibited V. anguillarum with a minimum inhibitory concentration (MIC) of 40 mg/L. At sub-inhibitory concentrations, esculetin effectively reduced biofilm formation and its key component extracellular polymeric substances (EPS) by 45.84% and 27.23%, respectively. Additionally, esculetin reduced bacterial swarming and swimming motility diameters by 6.67% and 25.76%, respectively, while partially suppressing extracellular protease and hemolytic activities. RT-qPCR (quantitative real-time PCR) analyses revealed that esculetin downregulated genes associated with the QS system (vanR, rpoN, vanT, and vanO) and virulence phenotypes (ompU, flaB, and hlyU). Molecular docking and dynamics simulations indicated that esculetin interacts with VanR and VanT proteins, with a stronger binding stability observed for VanT. In conclusion, esculetin acts as an effective QS inhibitor and shows potential as a novel candidate drug for controlling V. anguillarum infections, offering a new approach for the prevention and treatment of aquatic vibriosis.
Indexed as
Identifiers
42101705What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.